EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Steatosis to Systemic Metabolic Failure: Classical Pathophysiology, Emerging Systemic Mechanisms and Modifiable Lifestyle Determinants

Stefania Capuccio iD, Caterina Cocuzza, Grazia Letizia Di Marco, Alessandra Scamporrino iD, Salvatore Piro iD, Maurizio Russello iD

Nutrients · 15.07.2026 · 18 (14) · 2316

DOI: 10.3390/nu18142316 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 15.07.2026. Verfasst von Stefania Capuccio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy. Hauptthemen laut MEDLINE: Life Style, Fatty Liver, Non-alcoholic Fatty Liver Disease, Metabolic Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) represents the hepatic manifestation of systemic metabolic dysfunction and has emerged as one of the leading causes of chronic liver disease worldwide. Its pathogenesis is complex and multifactorial, involving insulin resistance, altered lipid metabolism, mitochondrial dysfunction, oxidative stress, and chronic low-grade inflammation. Beyond these classical mechanisms, growing evidence highlights the central role of modifiable lifestyle-related factors, including chronic positive energy balance, high intake of fructose and saturated fats, ultra-processed foods, physical inactivity, sleep disruption, and environmental exposures such as endocrine-disrupting chemicals and air pollution, which have been associated with the activation of lipogenic and proinflammatory pathways in preclinical and observational studies. Conversely, protective dietary patterns, particularly the Mediterranean diet, together with regular physical activity, exert hepatoprotective metabolic and anti-inflammatory effects. An extensive literature search was conducted across the PubMed, Scopus, Cochrane Library, and Embase databases, covering publications through June 2026. The review was conducted following the SANRA recommendations for narrative reviews. The inclusion criteria encompassed clinical trials, systematic reviews, meta-analyses, and international clinical practice guidelines. This review provides an integrated framework by linking in a single interpretative model the classical pathogenic pathways with emerging dietary, behavioral, and environmental determinants and with systemic interorgan communication networks involving hepatokines, adipokines, and myokines. Understanding MASLD as a multisystemic metabolic disease driven by multiple determinants has critical implications for the development of targeted preventive and therapeutic strategies aimed at reducing its global burden and prevalence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Life StyleFatty LiverNon-alcoholic Fatty Liver DiseaseMetabolic DiseasesHumansInsulin ResistanceOxidative StressDiet, MediterraneanDietLipid MetabolismRisk Factors

Stichwörter der Autor:innen

MASHMASLDdietary patternsgut–liver axishepatokinesinflammationinsulin resistanceliver fibrosismetabolic syndromenutritionoxidative stressprecision medicine

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy.
  • Department of Medicine and Surgery, "Kore" University of Enna, 94100 Enna, Italy.
  • Liver Unit, National and High-Specialization Hospital Trust Garibaldi-Nesima, 95122 Catania, Italy.

ORCID-Profile: Stefania Capuccio, Alessandra Scamporrino, Salvatore Piro, Maurizio Russello

Zitieren

APA

Capuccio, S., Cocuzza, C., Di Marco, G. L., Scamporrino, A., Piro, S., & Russello, M. (2026). Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Steatosis to Systemic Metabolic Failure: Classical Pathophysiology, Emerging Systemic Mechanisms and Modifiable Lifestyle Determinants. Nutrients, 18(14), 2316. https://doi.org/10.3390/nu18142316

Vancouver

Capuccio S, Cocuzza C, Di Marco GL, Scamporrino A, Piro S, Russello M. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Steatosis to Systemic Metabolic Failure: Classical Pathophysiology, Emerging Systemic Mechanisms and Modifiable Lifestyle Determinants. Nutrients. 2026;18(14):2316. doi:10.3390/nu18142316

BibTeX
@article{Capuccio2026,
  author = {Capuccio, Stefania and Cocuzza, Caterina and Di Marco, Grazia Letizia and Scamporrino, Alessandra and Piro, Salvatore and Russello, Maurizio},
  title = {Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Steatosis to Systemic Metabolic Failure: Classical Pathophysiology, Emerging Systemic Mechanisms and Modifiable Lifestyle Determinants},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {14},
  pages = {2316},
  doi = {10.3390/nu18142316}
}
Kostenlos starten →